ArticleAnnals of gastroenterology2014

An open-label, non-comparative, non-interventional, multi-center, post-authorization safety study on the administration of rabeprazole to adults with gastro-esophageal reflux disease.

Irini Zouboulis-Vafiadis et al.PubMed ↗Full text ↗

No numbers read from the abstract.